AstraZeneca Aktie
128,20
EUR
-0,95
EUR
-0,74
%
109,86
GBP
-0,44
GBP
-0,40
%
Werbung
AstraZeneca Aktie Analyse
03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.06.25 | AstraZeneca Buy | UBS AG | |
02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
16.05.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.05.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
29.04.25 | AstraZeneca Outperform | Bernstein Research | |
Werbung
|
|||
29.04.25 | AstraZeneca Buy | UBS AG | |
28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
22.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
10.04.25 | AstraZeneca Buy | UBS AG | |
09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
09.04.25 | AstraZeneca Outperform | Bernstein Research | |
03.04.25 | AstraZeneca Outperform | Bernstein Research | |
01.04.25 | AstraZeneca Buy | UBS AG | |
01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
17.03.25 | AstraZeneca Outperform | Bernstein Research | |
17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
17.03.25 | AstraZeneca Buy | UBS AG | |
17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
12.03.25 | AstraZeneca Buy | UBS AG | |
10.03.25 | AstraZeneca Buy | UBS AG | |
10.03.25 | AstraZeneca Buy | UBS AG | |
04.03.25 | AstraZeneca Outperform | Bernstein Research | |
26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.02.25 | AstraZeneca Outperform | Bernstein Research | |
19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
13.02.25 | AstraZeneca Buy | UBS AG | |
11.02.25 | AstraZeneca Outperform | Bernstein Research | |
10.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
13.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
07.01.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.01.25 | AstraZeneca Outperform | Bernstein Research | |
06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.12.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
03.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
25.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. |
Werbung
Werbung